Skip to main content
TEVA
NYSE Life Sciences

Teva Wins FDA Nod for At-Home Use of Igalmi in Schizophrenia Agitation

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$43.62
Mkt Cap
$50.932B
52W Low
$24.01
52W High
$44.57
52W Position info
82% above low
Off High info
2.1% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

TEVA sits 82% above its 52-week low of $24.01.

Summary

Teva secured an at-home indication for Igalmi in agitation associated with schizophrenia, expanding the drug beyond its prior supervised-use setting. The label broadening matters because at-home dosing opens a much larger addressable population than clinic- or ER-administered treatment, and it builds on the October FDA approval of Teva's monthly olanzapine injection for schizophrenia. This is a modest but real pipeline win for a company whose growth story leans on innovative medicines, following the Q3 beat and raised guidance on November 3 and the R&D Day targets of $6-7B in innovative revenue by 2030. Shares are trading near a 52-week high, so the news lands into an already-strong tape. BTAIQ, the other tagged ticker, is not a party to this approval.

At the time of this announcement, TEVA was trading at $43.62 on NYSE in the Life Sciences sector, with a market capitalization of approximately $50.9B. The 52-week trading range was $24.01 to $44.57. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

TEVA - Latest Insights

TEVA
Nov 11, 2026, 12:33 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $42.86
Real-time Price: $43.62 info
Change: +$0.755 (+2%) info
Market Cap: $50.85B info
TEVA
Nov 03, 2026, 7:58 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $41.60
Real-time Price: $43.62 info
Change: +$2.02 (+5%) info
Market Cap: $50.85B info
TEVA
Oct 09, 2026, 11:21 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $41.62
Real-time Price: $43.62 info
Change: +$2.00 (+5%) info
Market Cap: $50.85B info
TEVA
Sep 11, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.09
Real-time Price: $43.62 info
Change: +$6.52 (+18%) info
Market Cap: $50.85B info
TEVA
Sep 10, 2026, 6:04 AM EDT
Filing Type: FWP
Importance Score:
7
Price at Filing: $36.72
Real-time Price: $43.62 info
Change: +$6.90 (+19%) info
Market Cap: $50.85B info